EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PREX1 regulates renal fibrosis through the RPTOR-mTORC1 signaling pathway

Xiangyang Geng, Guang Chen, Yong Qian, Weimin Shan, Xiaowei Li, Jiehao Zhou, Xiao Wang

Cellular Signalling · 2027-01 · 149 · 112905

DOI: 10.1016/j.cellsig.2026.112905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2027-01. Verfasst von Xiangyang Geng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal fibrosis is a progressive pathological process driving chronic kidney disease (CKD) toward end-stage renal failure, yet effective anti-fibrotic therapies remain unavailable. The mTORC1 pathway critically promotes fibrosis by enhancing extracellular matrix (ECM) production and myofibroblast activation, but its upstream regulatory mechanisms in the kidney are poorly defined. Here, we identify PREX1 as a novel upstream activator of mTORC1 in renal fibrosis. We show that PREX1 drives fibrogenesis by positively regulating RPTOR, a core component of the mTORC1 complex. In human fibrotic kidneys and murine UUO models, PREX1 was markedly upregulated and closely correlated with ECM deposition. Mechanistically, PREX1 and RPTOR were found to reside in the same protein complex, and PREX1 increased RPTOR abundance; whether this association is direct was not determined. Silencing RPTOR abolished PREX1-driven S6K1 phosphorylation, placing RPTOR downstream of PREX1 in mTORC1 activation. Importantly, genetic silencing of either PREX1 or RPTOR, both in vitro and in vivo, significantly suppressed fibrotic and inflammatory responses and ameliorated renal pathology. Collectively, our findings uncover a novel PREX1-RPTOR-mTORC1 signaling axis that governs renal fibrogenesis and highlight the PREX1-RPTOR-mTORC1 axis as a promising therapeutic target for chronic kidney disease.

Schlagwörter

Stichwörter der Autor:innen

PREX1RPTORRenal fibrosismTORC1

Autor:innen und Institutionen

  • Department of Urology, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China.
  • Department of Nephrology, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China.
  • Department of Emergency Surgery, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China. Electronic address: 4711787@qq.com.
  • Department of Urology, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China. Electronic address: topwx1985@yeah.net.

Zitieren

APA

Geng, X., Chen, G., Qian, Y., Shan, W., Li, X., Zhou, J., & Wang, X. (2027). PREX1 regulates renal fibrosis through the RPTOR-mTORC1 signaling pathway. Cellular Signalling, 149, 112905. https://doi.org/10.1016/j.cellsig.2026.112905

Vancouver

Geng X, Chen G, Qian Y, Shan W, Li X, Zhou J, et al. PREX1 regulates renal fibrosis through the RPTOR-mTORC1 signaling pathway. Cellular Signalling. 2027;149:112905. doi:10.1016/j.cellsig.2026.112905

BibTeX
@article{Geng2027,
  author = {Geng, Xiangyang and Chen, Guang and Qian, Yong and Shan, Weimin and Li, Xiaowei and Zhou, Jiehao and Wang, Xiao},
  title = {PREX1 regulates renal fibrosis through the RPTOR-mTORC1 signaling pathway},
  journal = {Cellular Signalling},
  year = {2027},
  volume = {149},
  pages = {112905},
  doi = {10.1016/j.cellsig.2026.112905}
}
Kostenlos starten →